Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Insilico Biotechnology
Insilico Biotechnology
Activities:
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
You need to be a subscriber to read this article.
Click here
to find out more.
Industrial data mastery: navigating the 2025 landscape
As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Novo Holdings completes acquisition of Catalent
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
Newcells Biotech raises additional funding from investors
Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all
Related Content
Manufacturing
Yokogawa acquires bioprocessing digital twin expert
The company has acquired Insilico Biotechnology to build its biopharma offering
Finance
Insilico and 2-control work towards the smart biofactory
The agreement follows Insilico's previous collaboration with Meyer Chroma Technology
Manufacturing
Insilico Biotechnology moves into the US predictive twin market
Insilico Biotechnology has announced the opening of its first subsidiary in the US, located in Boston, Massachusetts
Manufacturing
Insilico and Janssen take another step towards predictive biomanufacturing
The digital twins collaboration will run for three years and will be based at Insilico's site in Stuttgart, Germany and at Janssen's Spring House location in the US
Manufacturing
Insilico works with university on digital twins for antibody production
The German collaboration aims to enable true online-control of critical quality attributes such as the glycosylation profile
Subscribe now